Add BrightSurf on Google Email

Predicting chemotherapy outcome

A research group identified 679 genes differently expressed in responders to chemotherapy compared to non-responders. RT-PCR analysis validated the findings, confirming the differential expression of 22 genes. The study suggests integrating molecular networks could improve diagnosis and treatment of colorectal cancer.

SourceBMC (BioMed Central)·JournalGenome Biology·DateMar 14, 2006

Studies report findings on colorectal cancer screening methods and survival rates

Regular screening significantly reduces cancer deaths in families with hereditary Lynch syndrome, with a 70% decrease in mortality rates. Additionally, research finds that people with IBD-related CRC have similar prognoses as the general population, while a self-propelling colonoscope shows promise in efficient and safe detection.

SourceAmerican Gastroenterological Association·JournalGASTROENTEROLOGY·DateMar 1, 2006

Novel function of APC

The APC tumor suppressor has a novel function in regulating Wnt signaling in the nucleus. In this new study, researchers demonstrate that APC opposes beta-catenin activity directly at Wnt target genes. The findings suggest that full-length APC protein is necessary to repress c-Myc gene expression and prevent colon cancer progression.

SourceCold Spring Harbor Laboratory·JournalGenes & Development·DateFeb 28, 2006

Chemotherapy given directly to the liver improves survival for patients with colorectal cancer

Researchers found that hepatic arterial infusion (HAI) therapy extended survival and improved quality of life in patients with colorectal cancer that has spread to the liver. HAI therapy resulted in a median survival of 24 months, better response rates, and longer time to disease progression compared to systemic chemotherapy.

SourceAmerican Society of Clinical Oncology·JournalJournal of Clinical Oncology·DateFeb 27, 2006

Other highlights in the January 18 JNCI

Research on women with HIV found that those infected with both HIV and high-risk HPV were at greatest risk of developing cervical cancer precursors. A study on postmenopausal women found sex hormone levels to be not associated with breast cancer risk, while another study suggested that BRCA2 mutation carriers had a fourfold increased i...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJan 17, 2006

Screening combination for PTs with colorectal cancer could reduce need for more invasive procedures

Researchers propose a simple test that identifies more accurately individuals who might have colorectal cancer when used alongside traditional guaiac tests. This new approach could decrease the number of false positives in screening programs and reduce the need for colonoscopy, potentially leading to improved accuracy and reduced costs.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateJan 5, 2006

Other highlights in the November 16 JNCI

A new study found that increased physical activity is associated with a decreased risk of breast cancer in both black women and white women, regardless of disease stage or family history. Additionally, research on plant compound deguelin suggests it may interfere with tobacco-induced lung cancer development, while high plasma levels of...

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 15, 2005

Largest study to date reveals baseline findings for flexible sigmoidoscopy

The largest study to date provides valuable insights into flexible sigmoidoscopy screening among 154,942 participants aged 55-74. Findings show that women are more likely to decline FSG than men, while non-acceptance increases with age in women. The rate of cancer detected was 2.9 per 1,000 individuals screened.

SourceUniversity of Pittsburgh Medical Center·JournalJNCI Journal of the National Cancer Institute·DateJul 5, 2005

Other highlights in the July 6 JNCI

A new study found long-duration regular use of aspirin or NSAIDs may lower prostate cancer risk by 18%. Gene variants associated with melanoma risk were also identified in a Mediterranean population study, while another study found no link between gene mutations and response to bevacizumab

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 5, 2005

Study links race to risk of advanced colorectal cancer, death

Researchers found that African Americans and Native Americans are more likely to be diagnosed with advanced disease and die of their disease compared to Asian Americans and non-Hispanic whites. The study highlights the importance of considering heterogeneity within broad racial/ethnic categories when evaluating cancer risks.

SourceWiley·JournalCancer·DateJun 27, 2005

Jefferson scientists create plant factories churning out antibodies against tumor cells

Researchers from Thomas Jefferson University have successfully created plant factories that produce antibodies against tumor cells, offering a potential alternative to expensive and traditional methods. The plant-made antibodies show similar effectiveness in inhibiting tumor growth as mammalian-made monoclonal antibodies.

SourceThomas Jefferson University·JournalProceedings of the National Academy of Sciences·DateMay 3, 2005

Virtual colonoscopy: Virtually promising

Researchers say virtual colonoscopy may be the answer to improving screening rates for colorectal cancer. The non-invasive test is highly sensitive and specific, while also being convenient and cost-effective, with minimal risk of side effects.

SourceIndiana University·JournalAnnals of Internal Medicine·DateApr 18, 2005

Important discovery about second most fatal cancer

A new syndrome of colorectal cancer has been identified, characterized by frequent mutations in the BRAF oncogene and DNA methylation. This inherited form of cancer often develops in previously harmless polyps and can occur in young individuals, emphasizing the importance of early detection and prevention.

SourceMcGill University·JournalClinical Gastroenterology and Hepatology·DateMar 3, 2005

Study examines effect of managed care on quality of care for cancer patients

A study published in the Journal of the National Cancer Institute found that increases in managed care market share were not associated with improved quality of care for cancer patients, except for a specific blood test. The authors conclude that expansion of managed care may not improve quality of care for all patients.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateFeb 15, 2005

Molecule predicts colon cancer patient survival

Researchers found that elevated levels of ávâ6 expression in colon carcinoma cells are associated with reduced patient survival. The molecule is identified as an independent prognostic marker for colorectal cancer and predictive of early-stage disease outcomes.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 20, 2005